The effect of standardized uptake value of18F-FDG-PET on prognosis of non-small cell lung cancer

Chinese Journal of Clinical Oncology

Volumn 33, Issue 3, 2006, Pages 167-170

  He, Shengli ^a   Guan, Yihui ^a   Zhao, Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Prognosis; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LUNG INJURY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; TUMOR CELL; UNIVARIATE ANALYSIS;

EID: 33644655713     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. David GP, David HJ, Christopher G, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 [J]. J Clin Oncol, 2004, 22 (2):330-353
2. Johan FV, Sigrid GS, Patrict JD, et al. Prognostic importance of the standardized uptake value on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography scan in no-small cell lung cancer: An analysis of 125 cases [J]. J Clin Oncol, 1999, 17(10):3201-3206
3. Mountain CF. Revisions in the international system for staging lung cancer[J]. Chest, 1997, 111(6):1710-1717
4. 18F-FDG-PET[J]. Radiology, 1994, 191(1):379-385
5. Kurokara T, Yoshida Y, Kawahara K, et al. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorode-2-deoxy-D-glucose uptake by positron emission tomography in epithelial tumors of the ovary[J]. Int J Cancer, 2004, 109(6):926-932
6. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms[J]. Cancer, 1987, 60:2682-2689
7. Vaupel P, Kallinowski F, Okunieff P. Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Humans Tumors: A Review[J]. Cancer, Res, 1989, 49(23):6449-6465
8. Brown RS, Leung JY. Glucose Transporterers and FDG Uptake in Untreated Primary Human NON-Small Cell Lung Cancer[J]. J Nucl Med, 1999, 40(4):556-565
9. 18F-FDG-PET Imaging in Patients with Non-Small Cell Lung Cancer[J]. Cancer, 1998, 83(5):918-924
10. 18F- FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer[J]. Eur J Nucl Med Mol Imaging, 2003, 30(1):63-71
11. Gennari A, Donati S, Salvadori B, et al. Role of 2-[18F]- Fluorodeoxyglucose (FDG) positron emission tomography (PET)in the early assessment of response to chemotherapy in metastatic breast cancer patients[J]. Clin Breast Cancer, 2000, 1(2):156-161
12. 18F- FDG-PET imaging in the management of non-small-cell lung cancer [J]. Ann Oncol, 2002, 13 (3):357-360
13. 18F]-FDG-PET imaging in small cell lung cancer [J]. Eur J Nucl Med Mol Imaging, 2003, 30(1):78-80